Меню
Идёт набор NCT06074744

Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty

Без фазы С лечением Joint Diseases Joint Pain

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: SSNB + IPACK, FNB + IPACK.
Кому может быть актуально
Состояния в реестре: Joint Diseases, Joint Pain. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Швейцария
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Subsartorial Saphenous Nerve Block (SSNB) Versus Femoral Nerve Block (FNB) in Primary Total Knee Arthroplasty (TKA) Combined With Infiltration Between Popliteal Artery and Capsule of the Knee (IPACK) - Where Are the Benefits?

Обзор

The goal of this clinical trial is to compare two different types of nerve blocks in patients undergoing surgery for primary Total Knee Arthroplasty. The main question aim to answer is: \- is there a benefit in functional muscle power output of the leg? Participants will be randomized into either the intervention group or the control group and: * receive Subsartorial Saphenous Nerve Block (SSNB) + IPACK in intervention group (group 1) * receive Femoral Nerve Block (FNB) + IPACK in control group (group 2) Researchers will compare the 2 groups to see if there are differences in : * functional muscle power output of the leg? * muscle function, mobility, clinical and radiological results, ROM, pain control (NRS), opioid consumption, length of hospital stay, patient satisfaction, mobility, reduction of costs?

Подробное описание

Prospective, randomized, double-blinded, single-center, controlled clinical trial with intervention group (SSNB + IPACK, group 1) and control group (FNB + IPACK, group 2), randomization by sealed envelopes.

The number of participants will be 72 per group, calculated based on a sample size calculator program.

The 3 surgeons will be blinded as well as the patients regarding the nerve block they will receive.

We will explain to the patients how both the blocks will be carried out, that 1 block will be located "higher on the leg" and 1 "lower on the leg". The nerve blocks will be carried out by a well-trained anaesthesiologist following standard procedures preoperative.

The IPACK will be applied by the surgeons intraoperative, following a standard protocol. The used implant for all patients will be the cemented ATTUNE™ Primary Knee System® (DePuySynthes Johnson\&Johnson).

Every patient will wear a brace fixed in full extension after surgery for the first 24 hours. Postoperative all patients will receive a standard set of adequate analgesics.

The postoperative rehabilitation program will follow our well-established physiotherapy scheme.

Performed assessments:

* Range of motion (ROM) * medical history * physical examinations * radiologic controls * adverse events * falls during hospital stay (standard protocol) * pain assessment (numeric rating scale) * Questionnaires (EQ-5D-5L und Oxford Knee Score) will be filled in by the patients * Functional assessment: Cycle sprint test one a specially instrumented indoor bike (Verve Info Tec PTY LTD) fit with an instrumented crank (InfoCrank Power Meter, Verve Cycling, West Perth, Australia) * Functional assessment: Manual muscle testing (MMT) * Functional assessment: Timed up and go test (TUG)

Superiority analysis using a two sample t-test, significance level 0.05, power 80%.

Data will be stored electronically in the data base (RedCap). In case of missing data there will always be attempts to obtain these data afterwards (contacting the patients by phone). Further on statistical analysis is performed.

Dropouts, before the 6 weeks follow-up, will be replaced by recruitment of new subjects.

For quality assurance the sponsor, the Ethics Committee or an independent trial monitor may visit the research sites.

Вмешательства

  • Другое SSNB + IPACK
    already included in arm/group description
  • Другое FNB + IPACK
    already included in arm/group description

Первичные конечные точки

  • Functional muscle power output of the leg [Срок оценки: preoperative, 6 weeks, 12 weeks, 1 year after surgery]
Вторичные конечные точки (9)
  • Muscle strength [Срок оценки: preoperative, 48 hours after surgery, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery]
  • Mobility [Срок оценки: preoperative, 48 hours after surgery, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks1 year after surgery]
  • Clinical results [Срок оценки: preoperative, day of discharge (7+/- 2 days postoperative), 6, 12 weeks, 1 year after surgery]
  • Radiological results [Срок оценки: preoperative(1-3), day 1 after surgery(1), 6 weeks(1-2), 1 year after surgery(1-3)]
  • Pain control [Срок оценки: before surgery, twice daily on the ward (except first 6 hours: hourly), day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery]
  • Opioid consumption [Срок оценки: before surgery, during hospital stay, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery]
  • Length of hospital stay [Срок оценки: before surgery, during hospital stay, day of discharge (7+/- 2 days postoperative), 6 weeks, 12 weeks, 1 year after surgery]
  • Patient satisfaction 1 [Срок оценки: preoperative, 6 weeks, 12 weeks, 1 year after surgery]
  • Patient satisfaction 2 [Срок оценки: preoperative, 6 weeks, 12 weeks, 1 year after surgery]

Критерии участия

Критерии включения

  • age > 18yrs
  • primary TKA
  • BMI 35kg/m2 or less
  • able to give informed consent as documented by signature
  • clinical history without any contraindications for the planned intervention

Критерии исключения

  • age < 18 years
  • revision-TKA
  • BMI >35kg/m2
  • absent contact information
  • inability or contraindications to undergo the investigated intervention (TKA, FNB, SSNB), - clinically significant concomitant diseases
  • pregnancy
  • inability to follow the procedures and follow-up procedures of the study (e.g. due to language problems, psychological disorders, dementia, living abroad, etc.
  • withdrawal from the study

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Четверное слепое
Основная цель
Лечение

Центры проведения

Швейцария · 1 центр
  • Luzerner Kantonsspital — Lucerne

Публикации

  • Declaration of Helsinki, Version October 2013
  • International Conference on Harmonization (ICH) E6(R2) Guideline for Good Clinical Practice
  • International Conference on Harmonization (ICH, 1997) E8 Guideline: General Considerations for Clinical Trials
  • Implantatregister SIRIS Hüfte und Knie: Kurzfassung - SIRIS Report 2022
  • Bundesamt für Statistik, Schweiz
  • Grosu I, Lavand'homme P, Thienpont E. Pain after knee arthroplasty: an unresolved issue. Knee Surg Sports Traumatol Arthrosc. 2014 Aug;22(8):1744-58. doi: 10.1007/s00167-013-2750-2. Epub 2013 Nov 8. PMID 24201900
  • Burket LW, Greenberg MS, Glick M. Burkett's Textbook of Oral Medicine. 10th ed. Philadelphia, PA: Lippincott
  • Winnie AP, Ramamurthy S, Durrani Z. The inguinal paravascular technic of lumbar plexus anesthesia: the "3-in-1 block". Anesth Analg. 1973 Nov-Dec;52(6):989-96. No abstract available. PMID 4796576

Идентификаторы

NCT: NCT06074744 · SSNB2023

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗